Focused ultrasound therapy provides a non-invasive, promising treatment option for prostate cancer, offering hope with fewer side effects and...
Vous n'êtes pas connecté
Combining the small-molecule protein therapy TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) with focused ultrasound (FUS) significantly
Focused ultrasound therapy provides a non-invasive, promising treatment option for prostate cancer, offering hope with fewer side effects and...
Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for growing brain tumors of...
Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute...
TUESDAY, Feb. 18, 2025 -- For patients with advanced prostate cancer (aPC), completion of a 12-week supervised exercise regimen leads to a...
Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious...
A decade-long follow-up from the ShortHER randomised clinical trial suggests that tumour-infiltrating lymphocytes (TILs) could play a pivotal role in...
TUESDAY, Feb. 18, 2025 -- Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in...
Elevated bfat mass and the obesity-associated protein/b (FTO) have been associated with enhanced tumor growth and resistance to immunotherapy. In
A new study suggests that a combination of radiation therapy and immune checkpoint inhibitors (ICIs) may offer a less invasive alternative to bladder...
WEDNESDAY, Feb. 19, 2025 -- For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair...